QV Bioelectronics

World-first implantable brain cancer therapy

Alderley Park, United Kingdom · Founded 2018 · $7.7M raised

Headquarters
Alderley Park
Founded
2018
Business Model
B2B
Total Funding
$7.7M
Last Round
$5.6M Series AJan 2026
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

VC-backed medical device startup developing GRACE (Glioma Resection Advanced Cavity Electric Field Therapy), an implantable electric field therapy device to treat glioblastoma (aggressive brain tumors). Device delivers continuous therapeutic electric fields to surgical cavity post-resection. Founders: Dr Christopher Bullock (CEO, biomedical engineer) and Dr Richard Fu (neurosurgeon).

Summary

QV Bioelectronics is an Advanced Materials company based in Alderley Park, United Kingdom, founded in 2018. It has raised $7.7M in total across 2 rounds, most recently a $5.6M Series A round in Jan 2026. Investors include PXN Ventures, Science Angel Syndicate and Fink Family Office.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AJan 2026
$5.6M

Sign up to see all 2 events

Funding: Pre-Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

QV Bioelectronics on Indexed.vc
<a href="https://indexed.vc/companies/qv-bioelectronics"><img src="https://indexed.vc/api/badge/company/qv-bioelectronics" alt="QV Bioelectronics on Indexed.vc" width="260" height="76" /></a>